Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Principais autores: | Mukhtyar, C, Luqmani, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2007
|
Registros relacionados
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
por: Mukhtyar, C, et al.
Publicado em: (2008) -
Eular recommendations for vasculitis
por: Luqmani, R, et al.
Publicado em: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
por: Mukhtyar, C, et al.
Publicado em: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
por: Mukhtyar, C, et al.
Publicado em: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
por: Mukhtyar, C, et al.
Publicado em: (2009)